Rybelsus vs. Victoza

See how Rybelsus and Victoza compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Rybelsus is a daily pill while Victoza is a daily injection, though both are GLP-1 receptor agonists approved for type 2 diabetes and cardiovascular risk reduction.

  • Both drugs carry a boxed warning for thyroid C-cell tumors and share nausea, diarrhea, and decreased appetite as common side effects.

  • Rybelsus is sometimes used off-label for weight loss in people without diabetes, while Victoza's higher-dose sibling Saxenda is FDA-approved for weight management.

Rybelsus vs. Victoza Drug Summary

Rybelsus

Rybelsus (semaglutide) is an oral GLP-1 receptor agonist used to control blood sugar in adults with type 2 diabetes and to lower cardiovascular risk in those with existing heart disease. It's taken as a tablet once a day on an empty stomach, starting at a low dose and increasing over about two months to a maintenance dose.

Victoza

Victoza (liraglutide) is an injectable GLP-1 receptor agonist used to manage blood sugar in adults and children 10 and older with type 2 diabetes, and to reduce cardiovascular risk in those with heart disease. It's given as a once-daily injection under the skin, with the dose increased weekly over about three weeks.

Rybelsus vs. Victoza Side Effects

Rybelsus

Most common
nausea (up to 20%)
diarrhea (up to 10%)
decreased appetite (up to 9%)
abdominal pain (up to 11%)

Victoza

Most common
nausea (up to 5%)
diarrhea (up to 12%)
decreased appetite (up to 5%)
vomiting (up to 5%)

Rybelsus vs. Victoza Dosage

Rybelsus

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 3 mg once daily Days 1-30
Maximum dose 14 mg once daily Day 61 onward
Dose changes 2 increases Every 30 days

Victoza

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 0.6 mg once daily Week 1
Maximum dose 1.8 mg once daily Week 3 onward
Dose changes 2 increases Every week

Rybelsus vs. Victoza Indications

Rybelsus

Rybelsus is FDA-approved to improve blood sugar control in adults with type 2 diabetes and to lower the risk of major cardiovascular events in those who already have heart disease. It's also used off-label, though not FDA-approved, for weight loss in people without diabetes.

  • Blood sugar control in type 2 diabetes

  • Cardiovascular risk reduction with heart disease

  • Off-label: weight loss without diabetes

Victoza

Victoza is FDA-approved to improve blood sugar control in adults and children 10 and older with type 2 diabetes, and to lower the risk of major cardiovascular events in those with existing heart disease. Its higher-dose version, Saxenda, is separately approved for chronic weight management.

  • Blood sugar control in type 2 diabetes

  • Cardiovascular risk reduction with heart disease

  • Approved for children 10 and older

Rybelsus vs. Victoza Pros and Cons

Rybelsus

Rybelsus offers the only oral option among GLP-1 receptor agonists, which can appeal to people who want to avoid needles. Because it's a pill, it requires strict dosing rules around food and water intake that injectable options don't need.

Pros

  • Only GLP-1 receptor agonist available as a pill

  • No injection or needle handling required

  • FDA-approved for cardiovascular risk reduction

  • Simple three-step titration schedule

Cons

  • Must be taken on an empty stomach with water

  • Requires waiting 30 minutes before eating or meds

  • Not approved for children

  • Not approved for chronic weight management

Victoza

Victoza has over a decade of real-world use and is approved for children as young as 10 with type 2 diabetes, unlike Rybelsus. Being an injection, it avoids the food and timing restrictions that come with an oral GLP-1 tablet.

Pros

  • Approved for children 10 and older with diabetes

  • No food or water timing restrictions

  • Long track record since 2010 approval

  • Higher-dose version (Saxenda) approved for weight loss

Cons

  • Requires daily self-injection

  • Needle disposal and site rotation needed

  • Needs refrigerated storage until first use

  • No oral option available

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.